Clinical Outcomes & Impact - 94% Improvement Rate Across 50,000+ Patients
In healthcare, outcomes are everything. Not promises, not credentials, not facilities - outcomes. At Athena Behavioral Health, our commitment to evidence-based treatment is matched by our commitment to measuring, tracking, and transparently reporting the results that treatment produces for our patients.
Our clinical outcomes data represents the real-world impact of our approach across more than 50,000 patients treated since our founding.
This page explains what our outcomes mean, how we measure them, and what patients and families can realistically expect from treatment at Athena.
Our Headline Outcomes
94% Clinical Improvement Rate
Athena's headline clinical outcome is a 94% improvement rate across all patients completing a primary course of treatment. This figure is calculated using validated clinical outcome measures administered at admission and at the point of treatment completion, including the Clinical Global Impression - Improvement scale (CGI-I), condition-specific tools such as the PHQ-9 (depression), GAD-7 (anxiety), and AUDIT (alcohol use), and patient-reported quality of life measures. A 'clinically significant improvement' is defined as a reduction in validated symptom scores meeting the threshold for meaningful change established in the clinical literature - not a marginal shift, but a genuine, measurable improvement in the condition that brought the patient to treatment.
50,000+ Patients Treated
Athena has treated over 50,000 patients across its facilities and programmes. This scale of clinical experience matters because it means our clinical team has encountered and successfully treated the full spectrum of presentations - from straightforward single-substance dependence to highly complex dual diagnosis cases with multiple co-occurring conditions and years of treatment-resistance.
How We Measure Outcomes
Athena uses a rigorous, multi-stage outcome measurement framework:
At Admission
All patients complete a standardised battery of validated clinical assessments at admission. These establish the baseline against which progress is measured and ensure that improvement claims are grounded in objective clinical data rather than subjective impression.
During Treatment
Weekly or bi-weekly progress assessments are conducted throughout the treatment process. These allow the clinical team to identify patients who are not progressing as expected, adapt treatment plans in real time, and ensure that every patient receives the intensity and type of treatment they actually need - not just what was initially planned.
At Discharge
Discharge assessments measure clinical change from admission baseline, using the same validated tools. These form the basis of our published improvement rate statistics.
At 3, 6, and 12 Months Post-Discharge
Athena tracks outcomes beyond the end of treatment, conducting follow-up assessments at 3, 6, and 12 months post-discharge. These assess sustained recovery, relapse rates, quality of life, and engagement with aftercare. Long-term follow-up data is the truest measure of treatment effectiveness - and the most important from a patient perspective.
Outcomes Across Specific Conditions
Alcohol Use Disorder
Among patients completing Athena's alcohol treatment programme, sustained abstinence or controlled drinking rates at 12-month follow-up consistently exceed national averages for addiction treatment. Liver function markers, quality of life scores, and family relationship measures all show significant improvement compared to admission baseline.
Depression
For patients presenting with major depression, PHQ-9 scores at discharge show an average reduction of 68% compared to admission, with the majority of patients moving from the 'moderate-severe' or 'severe' range at admission to the 'mild' or 'none' range at discharge.
Anxiety Disorders
GAD-7 scores for patients presenting with generalised anxiety show consistent improvement to below the clinical threshold in the majority of cases completing a full course of CBT-based treatment.
Dual diagnosis
Dual diagnosis co-occurring addiction and mental health conditions - is among the most clinically complex presentations. Athena's integrated approach achieves improvement rates comparable to single-diagnosis treatment, a finding that reflects the importance of addressing both conditions simultaneously rather than sequentially.
What the Numbers Mean for You
Statistics communicate population-level data. They tell you something important about the likelihood of a good outcome, but they cannot guarantee yours. What our outcomes data can tell you is that Athena's approach works for the overwhelming majority of patients who engage with it fully - and that the clinical systems, therapeutic expertise, and personalised care processes at Athena are specifically designed to maximise the chances of a positive outcome for every individual patient.
Frequently Asked Questions
How is the 94% improvement rate calculated?
The 94% rate reflects the proportion of patients completing a primary course of treatment at Athena who achieve a clinically significant improvement on standardised validated outcome measures, compared to their admission baseline scores.
What happens to patients who do not improve as expected?
Patients not progressing as expected are identified through our weekly monitoring process. The clinical team conducts a review, considers alternative diagnoses or treatment approaches, and adjusts the treatment plan accordingly. No patient is discharged without a clear plan, regardless of their progress trajectory.
Are these outcomes independently verified?
Athena's outcome data is collected using internationally validated clinical tools by trained clinical staff. We are committed to ongoing audit and quality improvement processes. We welcome scrutiny of our outcomes and encourage prospective patients and their families to ask our clinical team about the evidence base for our claimed results
